Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

Nature

Volumn 442, Issue 7105, 2006, Pages 916-919

  Baker, Matt ^a   Mackenzie, Ian R ^b   Pickering Brown, Stuart M ^c   Gass, Jennifer ^a   Rademakers, Rosa ^a   Lindholm, Caroline ^b   Snowden, Julie ^c   Adamson, Jennifer ^a   Sadovnick, A Dessa ^b   Rollinson, Sara ^c   Cannon, Ashley ^a   Dwosh, Emily ^b   Neary, David ^c   Melquist, Stacey ^a   Richardson, Anna ^c   Dickson, Dennis ^a   Berger, Zdenek ^a   Eriksen, Jason ^a   Robinson, Todd ^a   Zehr, Cynthia ^a   Dickey, Chad A ^a   Crook, Richard ^a   McGowan, Eileen ^a   Mann, David ^c   Boeve, Bradley ^d   Feldman, Howard ^b   Hutton, Mike ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOMES; DISEASES; GENETIC ENGINEERING; NEUROLOGY; PATHOLOGY; PATIENT TREATMENT; PROTEINS;

ALZHEIMER'S DISEASE; CYTOPLASMIC NEUROFIBRILLARY; FRONTOTEMPORAL DEMENTIA (FTD); GENE ENCODING;

DISEASE CONTROL;

PROGRANULIN; TAU PROTEIN;

CHROMOSOME; DISEASE INCIDENCE; GENE; HEALTH IMPACT; MUTATION; PATHOLOGY; PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CARCINOGENESIS; CELL NUCLEUS INCLUSION BODY; CENTROMERE; CHROMOSOME 17Q; CONTROLLED STUDY; DEGENERATIVE DISEASE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN TISSUE; INFLAMMATION; NULL ALLELE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

EID: 33746919083     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05016     Document Type: Article

References (31)

1. Brun, A. et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J. Neurol. Neurosurg. Psychiatry 57, 416-418 (1994).
2. Chow, T. W., Miller, B. L., Hayashi, V. N. & Geschwind, D. H. Inheritance of frontotemporal dementia. Arch. Neurol. 56, 817-822 (1999).
3. Hutton, M. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705 (1998).
4. Ingram, E. M. & Spillantini, M. G. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8, 555-562 (2002).
5. Rademakers, R. et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol. Psychiatry 7, 1064-1074 (2002).
6. Rosso, S. M. et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 124, 1948-1957 (2001).
7. Lendon, C. L. et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology 50, 1546-1555 (1998).
8. Kertesz, A. et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54, 818-827 (2000).
9. Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. Am. J. Med. Genet. 74, 380-385 (1997).
10. Bird, T. D. et al. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 48, 949-954 (1997).
11. van der Zee, J. et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 129, 841-852 (2006).
12. Mackenzie, I. R. et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129, 853-867 (2006).
13. Rademakers, R. et al. In IPSEN Meeting Research and Perspectives in Alzheimer's Disease: Genotype-Proteotype-Phenotype Relationships in Neurodegenerative Diseases (ed. Cummings, J.) 117-137 (Springer, Paris, 2005).
14. He, Z. & Bateman, A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J. Mol. Med. 81, 600-612 (2003).
15. Malaspina, A., Kaushik, N. & de Belleroche, J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77, 132-145 (2001).
16. Baker, C. A. & Manuelidis, L. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl Acad. Sci. USA 100, 675-679 (2003).
17. Neary, D., Snowden, J. S. & Mann, D. M. Classification and description of frontotemporal dementias. Ann. NY Acad. Sci. 920, 46-51 (2000).
18. Trojanowski, J. Q. & Dickson, D. Update on the neuropathological diagnosis of frontotemporal dementias. J. Neuropathol. Exp. Neurol. 60, 1123-1126 (2001).
19. Mackenzie, I. R. & Feldman, H. H. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J. Neuropathol. Exp. Neurol. 64, 730-739 (2005).
20. Foster, N. L. et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41, 706-715 (1997).
21. Mackenzie, I. R. & Feldman, H. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases. Acta Neuropathol. (Berl.) 105, 543-548 (2003).
22. Cruts, M. et al. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region. Hum. Mol. Genet. 14, 1753-1762 (2005).
23. Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature advance online publication, doi:10.1038/nature05017 (16 July 2006).
24. Maquat, L. E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Rev. Mol. Cell Biol. 5, 89-99 (2004).
25. Daniel, R., He, Z., Carmichael, K. P., Halper, J. & Bateman, A. Cellular localization of gene expression for progranulin. J. Histochem. Cytochem. 48, 999-1009 (2000).
26. Capsoni, S. et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl Acad. Sci. USA 97, 6826-6831 (2000).
27. Salehi, A., Delcroix, J. D. & Swaab, D. F. Alzheimer's disease and NGF signaling. J. Neural Transm. 111, 323-345 (2004).
28. Lu, R. & Serrero, G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proc. Natl Acad. Sci. USA 98, 142-147 (2001).
29. Tangkeangsirisin, W. & Serrero, G. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25, 1587-1592 (2004).
30. Greenway, M. J. et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nature Genet. 38, 411-413 (2006).
31. He, Z., Ong, C. H., Halper, J. & Bateman, A. Progranulin is a mediator of the wound response. Nature Med. 9, 225-229 (2003).